Full View

Targeting B cells in relapsing–remitting multiple sclerosis: from pathophysiology to optimal clinical management

S Bittner, T Ruck, H Wiendl… - Therapeutic …, 2017 - journals.sagepub.com
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease that is caused by an
autoimmune response against central nervous system (CNS) structures. Traditionally …
被引用次数：85 相关文章

Targeting B cells in relapsing-remitting multiple sclerosis: from pathophysiology to optimal clinical management

S Bittner, T Ruck, H Wiendl… - Therapeutic …, 2017 - pubmed.ncbi.nlm.nih.gov
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease that is caused by an
autoimmune response against central nervous system (CNS) structures. Traditionally …
[HTML] nih.gov

[HTML][HTML] Targeting B cells in relapsing–remitting multiple sclerosis: from pathophysiology to optimal clinical management

S Bittner, T Ruck, H Wiendl, OM Grauer… - Therapeutic Advances …, 2017 - ncbi.nlm.nih.gov
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease that is caused by an
autoimmune response against central nervous system (CNS) structures. Traditionally …

Targeting B cells in relapsing-remitting multiple sclerosis: from pathophysiology to optimal clinical management.

S Bittner, T Ruck, H Wiendl, OM Grauer… - Therapeutic Advances …, 2016 - europepmc.org
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease that is caused by an
autoimmune response against central nervous system (CNS) structures. Traditionally …

Targeting B cells in relapsing-remitting multiple sclerosis: from pathophysiology to optimal clinical management.

S Bittner, T Ruck, H Wiendl, OM Grauer… - Therapeutic Advances …, 2016 - europepmc.org
Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease that is caused by an
autoimmune response against central nervous system (CNS) structures. Traditionally …